In 2022, the global biomarkers market was valued at US$ 51.2 billion. Projections indicate that the market will advance at a CAGR of 10.4% from 2023 to 2031, surpassing US$ 125.6 billion by 2031. This robust growth is fueled by expanding applications of biomarkers in oncology, cardiology, neurology, and infectious diseases. The market expansion is also driven by the growing role of... https://www.transparencymarketresearch.com/biomarkers-market.html